Prevention of First Decompensation in Advanced Chronic Liver Disease
Open Access
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 25 (2) , 291-310
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
This publication has 101 references indexed in Scilit:
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyThe Lancet, 2013
- Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus InfectionClinical Gastroenterology and Hepatology, 2011
- Long-term Outcomes of Patients With Autoimmune Hepatitis Managed at a Nontransplant CenterGastroenterology, 2011
- Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C†,‡,§,¶Hepatology, 2010
- Portal Hypertension and Primary Biliary Cirrhosis: Effect of Long-Term Ursodeoxycholic Acid TreatmentGastroenterology, 2008
- Beta-Blockers to Prevent Gastroesophageal Varices in Patients with CirrhosisNew England Journal of Medicine, 2005
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseNew England Journal of Medicine, 2004
- Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosisJournal of Hepatology, 2004
- Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective studyGastroenterology, 1996
- Portal hypertension in primary biliary cirrhosisJournal of Hepatology, 1987